BHIC.US BHIC
- Market cap
- USD 59.1M
- P/E
- -
- P/B
- 32.22x
- ROE
- -45.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is BHIC.US undervalued?
Graham numberThe Graham number of BHIC cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
BHIC fundamental analysis
No fundamental analysis for BHIC yet.
BHIC stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About BHIC
BioScience Health Innovations, Inc. operates as a health and wellness innovation company focuses on mitochondrial health science, advanced peptide delivery, and metabolic care in the United States. It offers nutritional supplements, peptides, and bioactive compounds through its core technology Mineral Oxide Delivery System, as well as provides Oracle NetSuite, an accounting and financial reporting system. The company also provides services, including testosterone and hormona…
Full company profileBHIC financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
BHIC annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 69.3K | 598K | 1.84M | 5.69M | 3.57M |
| Gross Profit | 59.6K | 484K | 1.31M | 3.24M | 2.29M |
| Operating Income | -170K | -252K | 87.0K | 719K | -896K |
| EBITDA | -170K | -252K | 87.0K | 719K | -896K |
| Net Income | -170K | -252K | 87.0K | 642K | -831K |
| EPS | -0.12 | -0.02 | 0.01 | 0.06 | -0.07 |
| Balance Sheet | |||||
| Total Assets | 31.6K | 93.4K | 874K | 1.71M | 2.14M |
| Total Liabilities | 48.8K | 100K | 38.5K | 230K | 301K |
| Shareholders' Equity | -17.2K | -6.76K | 835K | 1.48M | 1.83M |
| Cash & Short-term Investments | 11.6K | 19.2K | 663K | 662K | 712K |
| Cash Flow | |||||
| Operating Cash Flow | -183K | -308K | 23.2K | 172K | -2.19M |
| Capital Expenditure | 0.00 | 0.00 | 26.0K | 56.9K | 0.00 |
| Free Cash Flow | -183K | -308K | -2.85K | 115K | -2.24M |
| Ratios | |||||
| ROE | - | - | 10.4% | 43.5% | -45.3% |
| ROA | -539.3% | -269.3% | 10.0% | 37.6% | -38.9% |
| Net Profit Margin | -245.8% | -42.1% | 4.7% | 11.3% | -23.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
BHIC dividends
BHIC has not paid dividends in the last 4 fiscal years.
Last stock split: 1:4 on Sep 26, 2025.
Who owns BHIC
- Insiders 42.99%
- Institutions 0.00%
- Public & others 57.01%
- Shares outstanding 11.8M
- Free float 6.70M
BHIC company profile
- Company name
- BHIC
- Ticker
- BHIC.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Fiscal year end
- December
- Address
- 14857 South Concord Park Drive, Bluffdale, UT, United States, 84065
- Phone
- 801 949 0791
About BHIC
BioScience Health Innovations, Inc. operates as a health and wellness innovation company focuses on mitochondrial health science, advanced peptide delivery, and metabolic care in the United States. It offers nutritional supplements, peptides, and bioactive compounds through its core technology Mineral Oxide Delivery System, as well as provides Oracle NetSuite, an accounting and financial reporting system. The company also provides services, including testosterone and hormonal Optimization, NAD+ and cellular health, and platform licensing and peptide delivery. It sells its products through Amazon platform; and direct-to-consumer. The company was formerly known as Nowtransit Inc and changed its name to BioScience Health Innovations, Inc. in February 2025. BioScience Health Innovations, Inc. is based in Bluffdale, Utah.
BHIC management
3- Mr. Darren J. Lopez M.B.A.Chairman of the Board, CEO & President · born 1977
- Mr. John ChymborykCFO & Director · born 1955
- Mr. Daniel SchmidtCTO & Director · born 1965